Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Arthur J. Gallagher & Co. (AJG)

Page 1 of 2

Arthur J. Gallagher & Co. (NYSE:AJG) was in 21 hedge funds’ portfolio at the end of the first quarter of 2013. AJG has seen an increase in support from the world’s most elite money managers of late. There were 13 hedge funds in our database with AJG positions at the end of the previous quarter.

Arthur J. Gallagher & Co. (NYSE:AJG)

To the average investor, there are dozens of metrics market participants can use to monitor their holdings. A pair of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite money managers can trounce the market by a solid margin (see just how much).

Just as beneficial, bullish insider trading activity is another way to parse down the marketplace. Just as you’d expect, there are plenty of motivations for an executive to sell shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Many academic studies have demonstrated the useful potential of this method if investors know where to look (learn more here).

Consequently, we’re going to take a look at the key action regarding Arthur J. Gallagher & Co. (NYSE:AJG).

Hedge fund activity in Arthur J. Gallagher & Co. (NYSE:AJG)

Heading into Q2, a total of 21 of the hedge funds we track were bullish in this stock, a change of 62% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were increasing their holdings meaningfully.

According to our comprehensive database, Citadel Investment Group, managed by Ken Griffin, holds the largest position in Arthur J. Gallagher & Co. (NYSE:AJG). Citadel Investment Group has a $162.3 million position in the stock, comprising 0.2% of its 13F portfolio. Coming in second is Chuck Royce of Royce & Associates, with a $62.2 million position; 0.2% of its 13F portfolio is allocated to the stock. Other hedge funds that are bullish include Jim Simons’s Renaissance Technologies, Israel Englander’s Millennium Management and Phill Gross and Robert Atchinson’s Adage Capital Management.

As industrywide interest jumped, some big names were leading the bulls’ herd. Renaissance Technologies, managed by Jim Simons, created the most outsized position in Arthur J. Gallagher & Co. (NYSE:AJG). Renaissance Technologies had 32.2 million invested in the company at the end of the quarter. Martin D. Sass’s MD Sass also initiated a $21 million position during the quarter. The following funds were also among the new AJG investors: Donald Chiboucis’s Columbus Circle Investors, James Dondero’s Highland Capital Management, and Glenn Russell Dubin’s Highbridge Capital Management.

What have insiders been doing with Arthur J. Gallagher & Co. (NYSE:AJG)?

Insider buying is at its handiest when the company in question has seen transactions within the past 180 days. Over the last half-year time period, Arthur J. Gallagher & Co. (NYSE:AJG) has experienced zero unique insiders purchasing, and 12 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Arthur J. Gallagher & Co. (NYSE:AJG). These stocks are Marsh & McLennan Companies, Inc. (NYSE:MMC), Aon PLC (NYSE:AON), Erie Indemnity Company (NASDAQ:ERIE), Willis Group Holdings PLC (NYSE:WSH), and Brown & Brown, Inc. (NYSE:BRO). This group of stocks are the members of the insurance brokers industry and their market caps match AJG’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!